KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Taxes (2016 - 2019)

Arbutus Biopharma's Change in Taxes history spans 6 years, with the latest figure at -$2000.0 for Q4 2019.

  • For Q4 2019, Change in Taxes changed N/A year-over-year to -$2000.0; the TTM value through Dec 2019 reached -$100000.0, changed N/A, while the annual FY2018 figure was $49000.0, 4.26% up from the prior year.
  • Change in Taxes for Q4 2019 was -$2000.0 at Arbutus Biopharma, up from -$98000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $164000.0 in Q4 2015 and bottomed at -$294000.0 in Q2 2017.
  • The 5-year median for Change in Taxes is $0.0 (2018), against an average of -$16600.0.
  • The largest annual shift saw Change in Taxes surged 210.2% in 2017 before it plummeted 5000.0% in 2019.
  • A 5-year view of Change in Taxes shows it stood at $164000.0 in 2015, then crashed by 40.24% to $98000.0 in 2016, then tumbled by 162.24% to -$61000.0 in 2017, then surged by 103.28% to $2000.0 in 2018, then tumbled by 200.0% to -$2000.0 in 2019.
  • Per Business Quant, the three most recent readings for ABUS's Change in Taxes are -$2000.0 (Q4 2019), -$98000.0 (Q1 2019), and $2000.0 (Q1 2018).